Pre-market: BANB.SW Bachem Holding AG (SIX) -13.68% Feb 24 2026: watch CHF56.15
We saw BANB.SW stock fall sharply in pre-market trading on 24 Feb 2026, down 13.68% to CHF56.15 on heavy volume. The move follows an early open at CHF64.50 and a previous close of CHF65.05, with intraday range CHF55.65–CHF64.50. We view the drop as a headline-driven sell-off ahead of the company’s earnings window and a technical unwind — volume is 529,199 versus an average 116,992, flagging outsized selling. Below we unpack valuation, technicals, Meyka grade and short-term price targets for investors on the SIX Swiss Exchange.
BANB.SW stock quick snapshot
BANB.SW stock (Bachem Holding AG, SIX, Switzerland) trades at CHF56.15 after a -13.68% pre-market decline on 24 Feb 2026. Market cap is CHF4.21B with 74,977,940 shares outstanding. Key daily levels: open CHF64.50, low CHF55.65, high CHF64.50. Trading volume is 529,199, or 4.52x average, signalling accelerated selling pressure.
What moved the price: events and technicals
We link the drop to positioning ahead of the next earnings announcement on 12 Mar 2026 and to a negative re-rating visible in sentiment data. Technical indicators show the stock is oversold: RSI 28.21, CCI -265.98, and MACD histogram negative. ADX at 27.51 indicates the move has trend strength. High relative volume supports an aggressive distribution day rather than normal profit-taking.
Fundamentals and valuation for BANB.SW stock
Bachem reports EPS CHF1.79 and a trailing PE 31.37, above the Basic Materials sector average PE 18.13, implying a premium valuation. Price-to-book is 3.10, EV/EBITDA 22.26, and dividend per share CHF0.85 (yield 1.51%). Margins remain healthy with net margin 19.79% and operating margin 24.12%, but free cash flow per share is negative at CHF-1.59, highlighting near-term cash conversion pressure.
Meyka AI grade and model forecast for BANB.SW stock
Meyka AI rates BANB.SW with a score out of 100: 70.99 (B+) — Suggestion: BUY. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst consensus. Meyka AI’s forecast model projects monthly CHF55.47, quarterly CHF66.59, yearly CHF45.06 and 3-year CHF21.43. Versus the current CHF56.15, that implies short-term downside -1.20%, quarterly upside +18.60%, 12-month downside -19.76%, and 3-year downside -61.86%. Forecasts are model-based projections and not guarantees.
Risks and catalysts for investors
Primary near-term catalysts: the earnings release on 12 Mar 2026 and any updates on peptide/oligonucleotide contract wins. Risks include high inventory days (378.02) and negative free cash flow yield -2.83%, which may pressure sentiment if cash conversion does not improve. Sector headwinds in Basic Materials/ Chemicals and a higher-than-average PE multiple raise valuation risk relative to peers.
Trading checklist and price targets
For traders we highlight immediate support at CHF55.00 and resistance near the open at CHF64.50. Short-term tactical price targets: defensive support CHF50.00, neutral fair-value CHF60.00, and conservative downside target CHF45.06 (Meyka 12‑month model). Use strict size limits given elevated volatility and confirmed technical oversold readings. See the company site and exchange filings for event-driven updates: Bachem IR and SIX Swiss Exchange. Internal data page: BANB.SW on Meyka.
Final Thoughts
BANB.SW stock opened the pre-market on 24 Feb 2026 at CHF64.50 and plunged to CHF56.15, a -13.68% move driven by heavy volume and pre-earnings repositioning. Fundamentals show solid margins and a modest dividend, but valuation metrics like PE 31.37 and PB 3.10 trade at premiums to the Chemicals peer group. Meyka AI rates the stock 70.99/100 (B+) — Suggestion: BUY, while its model gives a mixed set of outcomes: a near-term monthly projection at CHF55.47 (-1.20% vs today) and a quarterly projection at CHF66.59 (+18.60%). Investors should weigh the short-term technical oversold condition (RSI 28.21) and elevated inventory and cash conversion risks before adding exposure. For active traders, a cautious approach with tight stops and monitoring of the 12 Mar 2026 earnings release is prudent. Forecasts are model-based and not guarantees; we use them as part of a broader risk-managed process in our AI-powered market analysis platform, Meyka AI.
FAQs
Why did BANB.SW stock fall so sharply pre-market?
The decline to CHF56.15 reflects heavy selling ahead of the 12 Mar 2026 earnings date, large relative volume (529,199 vs avg 116,992), and technical unwind. No single public news item explains the whole move; positioning and valuation repricing likely contributed.
What are the key valuation metrics for BANB.SW stock?
Bachem shows EPS CHF1.79, trailing PE 31.37, PB 3.10, EV/EBITDA 22.26, and dividend yield 1.51%. PE is above the Basic Materials sector average, signalling a premium valuation.
What price targets does Meyka AI provide for BANB.SW stock?
Meyka AI’s model projects monthly CHF55.47 (-1.20%), quarterly CHF66.59 (+18.60%), yearly CHF45.06 (-19.76%) and 3-year CHF21.43 (-61.86%). These are model projections and not guarantees.
How should traders manage risk on BANB.SW stock now?
Given RSI 28.21 and high volatility, use small position sizes, tight stops, and watch support at CHF55.00 and resistance at CHF64.50. Monitor the 12 Mar 2026 earnings release closely before adding exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.